Drug combo may cut opioid use after lung surgery

NCT ID NCT06837519

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial tests whether giving lidocaine, dexmedetomidine, or both during video-assisted thoracoscopic surgery (VATS) can reduce pain and the need for morphine afterward. Adults undergoing VATS under general anesthesia will receive one of the two drugs or a combination. The main goal is to see how much morphine patients need after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lidocaine and dexmedetomidine infusions, alone or combined
What this could lead to
If successful, this combination could offer better pain control and reduce the need for morphine after lung surgery.
What could go wrong
This is a small, early-phase trial, so results may not apply broadly. Both drugs can cause side effects like low blood pressure or slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEXMEDETOMIDINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ain Shams University

    Cairo, 11591, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.